UK patients seek compensation after taking rofecoxib

BMJ 2004; 329 doi: (Published 02 December 2004) Cite this as: BMJ 2004;329:1308
  1. Clare Dyer, legal correspondent
  1. BMJ

    British lawyers are gearing up to launch a mass compensation claim in the British courts on behalf of hundreds of patients who had strokes or heart attacks after taking the arthritis drug rofecoxib (Vioxx).

    Two law firms, Leigh, Day & Co and Irwin Mitchell, investigated the possibility of suing the manufacturer, Merck, …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription